Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Satsuma Pharmaceuticals Inc
(NQ:
STSA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Satsuma Pharmaceuticals Inc
< Previous
1
2
3
Next >
Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
June 09, 2023
The Dow Jones closed higher by over 160 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
April 18, 2023
Via
Benzinga
Why Is Satsuma Pharmaceuticals (STSA) Stock Down 80% Today?
November 14, 2022
STSA stock is dropping after Satsuma Pharmaceuticals reported that its lead migraine drug candidate failed to meet expectations.
Via
InvestorPlace
Crude Oil Down 2%; State Street Shares Tumble After Downbeat Results
April 17, 2023
U.S. stocks traded slightly lower toward the end of trading. The Dow traded down 0.07% to 33,862.05 while the NASDAQ fell 0.24% to 12,093.82. The S&P 500, also fell, dropping, 0.17% to 4,130.78.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 17, 2023
Via
Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 17, 2023
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.
Via
Benzinga
Gold Drops Below $2,000; Charles Schwab Earnings Top Views
April 17, 2023
U.S. stocks traded mostly flat midway through trading, following the release of economic data. The Dow traded up 0.01% to 33,890.03 while the NASDAQ fell 0.18% to 12,101.34. The S&P 500, also fell,...
Via
Benzinga
Why Is SAI.TECH Global (SAI) Stock Down 32% Today?
April 17, 2023
SAI.TECH Global (SAI) stock is down on Monday despite a lack of news concerning the Bitcoin (BTC-USD) mining and clean energy company.
Via
InvestorPlace
Why Is Marpai (MRAI) Stock Down 40% Today?
April 17, 2023
Marpai (MRAI) stock is taking a beating on Monday after the company announced a proposed public offering for its shares.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 17, 2023
Via
Benzinga
Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today?
April 17, 2023
Prometheus Biosciences (RXDX) stock is on the rise Monday after the company revealed a $10.8 billion acquisition deal with Merck (MRK).
Via
InvestorPlace
Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket
April 17, 2023
Gainers CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 153% to $5.96 in pre-market trading after jumping 243% on Friday.
Via
Benzinga
Why Is Satsuma Pharmaceuticals (STSA) Stock Up 144% Today?
April 17, 2023
Satsuma Pharmaceuticals (STSA) stock is taking off on Monday after revealing an acquisition deal with Shin Nippon Biomedical Laboratories.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 17, 2023
We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 07, 2023
Via
Benzinga
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 17, 2023
Gainers Ibio Inc (NYSE: IBIO) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 26, 2022
Via
Benzinga
Despite Trial Failure, Satsuma Pharma Says Its Migraine Candidate Has Potential For Approval
December 20, 2022
Satsuma Pharmaceuticals Inc (NASDAQ: STSA) provided an update on its STS101 development program and corporate update.
Via
Benzinga
Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday's Mid-Day Session
November 17, 2022
Gainers Elevate Credit, Inc. (NYSE: ELVT) shares surged 71.2% to $1.8150 after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 17, 2022
Via
Benzinga
Why NetEase Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket
November 17, 2022
Gainers
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Satsuma Pharmaceuticals: Here's What You Need To Know
November 15, 2022
Via
Benzinga
Expert Ratings for Satsuma Pharmaceuticals
November 15, 2022
Over the past 3 months, 6 analysts have published their opinion on Satsuma Pharmaceuticals (NASDAQ:STSA) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...
Via
Benzinga
Dow Surges 150 Points; Crude Oil Falls Sharply
November 14, 2022
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday.
Via
Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 14, 2022
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
November 14, 2022
Monday saw 33 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 14, 2022
Gainers
Via
Benzinga
Silver Rises Over 1%; Tyson Foods Posts Downbeat Earnings
November 14, 2022
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping around 60 points on Monday.
Via
Benzinga
US Stocks Mostly Lower; Nasdaq Drops Over 100 Points
November 14, 2022
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.